Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Spinal Cord Stimulator Helps Treat Chronic Pain

By HospiMedica International staff writers
Posted on 12 Feb 2019
A new spinal cord stimulator (SCS) system combines paraesthesia and sub-perception therapy to treat chronic and debilitating pain.

The Boston Scientific (Natick, MA, USA) Spectra WaveWriter is an implanted SCS system designed to help in the management of chronic obdurate pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable lower back and leg pain, complex regional pain syndrome (CRPS), radicular pain syndrome, and radiculopathies resulting in secondary pain, such as failed back surgery, a herniated disc, degenerative disc disease (DDD), and others.

The two main components of the system are the signal generator, implanted under the skin, which sends electrical stimulation signals to the spinal cord through an insulated lead wire, and a hand-held remote control that allows the patient to control it. More...
The signal generator is programmed to produce electrical signals that can block pain signals traveling to the patient's brain through a combination of novel sub-perception algorithms and waveform automation. Studies have shown an improvement in pain of 29.2-100% for CRPS patients, and 37-77% for those with back and leg pain due to surgery-associated conditions.

“We are introducing industry-leading SCS technology to help provide patients with lasting relief from chronic pain,” said Maulik Nanavaty, president and senior vice president of neuromodulation at Boston Scientific. “We are committed to investing in research and expanding treatment options for chronic pain by identifying new, non-opioid solutions for the millions of people suffering from this debilitating condition.”

“Pain is very personal, and everyone experiences it differently. Pain also changes over time, which for chronic pain patients means that their bodies may become accustomed to treatment and its effectiveness declines,” said Vivek Mehta, a consultant in pain medicine at Queen Mary, University of London (QMUL; United Kingdom). “The Spectra WaveWriter SCS system allows us to combine multiple treatment options in one single device, intended to give patients truly personalized therapy that evolves just as their pain does to provide lasting relief.”

SCS works by sending electrical impulses to the spinal cord, masking the pain signals travelling to the brain. These electrical impulses can vary in frequency, pulse width, and amplitude, providing pain relief with a light tingling sensation known as paraesthesia-based therapy or with sub-perception therapy that works without sensation.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.